You have seen them. The patients who walk into your clinic with a peptide shopping list, asking for semaglutide for weight loss and BPC 157 for joint pain, while surviving on four BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157 Calgary Peptides (PC) BPC 157: Experimental Peptide Creates Risk for Athletes